Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Amphora Discovery

2001 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Provider of pathway-based drug discovery services. The company's lead generation platform delivers unmatched precision, selectivity and data quality, which has produced well characterized proprietary new clinical entities for use in oncology, inflammation, metabolic diseases and neurological disorders. Amphora's most advanced compounds are preclinical candidates in the areas of oncology and inflammation which are exquisitely specific inhibitors for AKT1 and p38 respectively.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Discovery Tools (Healthcare)
Acquirer
Nanosyn
Primary Office
  • 800 Capitola Drive
  • Suite 4
  • Durham, NC 27713
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Amphora Discovery’s full profile, request a free trial.

Amphora Discovery Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 21-Oct-2008 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Feb-2006 00.000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 30-May-2005 00.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 08-Dec-2004 0000 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Dec-2002 $23M $48M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2001 $25M $25M 0000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Amphora Discovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00
Series E 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.00 00.000
Series A1 23,750,000 $0.001000 $0.08 $1 $1 1x $0.71 20.22%
Series A 1,300,000 $0.001000 $0.08 $100000
To view this company’s complete Cap Table, request access »

Amphora Discovery Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3i Group PE/Buyout Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Aventis Corporation Minority 000 0000 000000 0
CW Group Venture Capital Minority 000 0000 000000 0
Chevron Technology Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »